• 1:头版
  • 2:焦点
  • 3:焦点
  • 4:财经要闻
  • 5:金融·证券
  • 6:金融·证券
  • 7:观点评论
  • 8:时事·国内
  • A1:市场
  • A2:基金
  • A3:货币债券
  • A4:期货
  • A5:策略·数据
  • A6:行业·个股
  • A7:热点·博客
  • A8:理财
  • B1:公 司
  • B2:上市公司
  • B3:上市公司
  • B4:产业·公司
  • B5:产业·公司
  • B6:产业调查
  • B7:上证研究院·金融广角镜
  • B8:人物
  • C1:披 露
  • C3:信息披露
  • C4:信息披露
  • C5:信息披露
  • C6:信息披露
  • C7:信息披露
  • C8:信息披露
  • C9:信息披露
  • C10:信息披露
  • C11:信息披露
  • C12:信息披露
  • C13:信息披露
  • C14:信息披露
  • C15:信息披露
  • C16:信息披露
  •  
      2008 年 10 月 16 日
    前一天  后一天  
    按日期查找
    A5版:策略·数据
    上一版  下一版  
    pdf
     
     
      | A5版:策略·数据
    经济底部预期明朗提振市场信心
    人民币对美元明年可能贬值2%
    次贷危机有继续向深度蔓延可能
    医改意见稿公布把握四类投资机会
    强势个股机构最新评级(10月15日)
    热门板块机构调研深度透析(10月15日)
    全球金融危机中的中国机遇
    稳定收益预期是A股市场应对全球金融危机的根本
    更多新闻请登陆中国证券网〉〉〉
     
     
    上海证券报网络版郑重声明
       经上海证券报社授权,中国证券网独家全权代理《上海证券报》信息登载业务。本页内容未经书面授权许可,不得转载、复制或在非中国证券网所属服务器建立镜像。欲咨询授权事宜请与中国证券网联系 (8621-38967588 ) 。

    标题: 作者: 正文: 起始时间: 截止时间:
      本版导航 | 版面导航 | 标题导航 收藏 | 打印 | 推荐  
    热门板块机构调研深度透析(10月15日)
    2008年10月16日      来源:上海证券报      作者:
      热门板块机构调研深度透析(10月15日)

    名称                             机构        

    板块     市场表现调研结论评级/     关注个股

                                                                                                                                                                                                                                                                                                                                                                                   君安                 华夏银行

                                                                                                                                                                                                                                                                                                                                 /                        

                                                                                                                                                                                                                                                                                                                                 增持                

                                                                                                                                                                                                                                                                                                                                                                                                     证券                 益佰制药

                                                                                                                                                                                                                                                                                                                                 /                        

                                                                                                                                                                                                                                                                                                                                 看好                

                                                                                                                                                                                                                                                                                                                        证券                 绿景地产

                                                                                                                                                                                                                                                                                                                                 /                    

                                                                                                                                                                                                                                                                                                                                 中性                

    银行          银行股在周二大涨基础上,周三再度表现为强势整理态势。     国内绝大多数银行均未受次贷波及,预计三季报和年报依然能够实现大幅增长。当前银行股股价已经充分反映了负面因素的利空效应,而未来银行股有望成为管理层救市的支撑点。国泰             浦发银行

    医药          经过两日蓄势整理后,昨日医药板块逆市走高。     医改征求意见稿出台后,药品消费的市场结构也将随之改变。医疗市场的两头将可能是国产药的天下,中间段将成为高端市场,配合相关政策,国产药消费比重将可能上升。中投             华北制药

    行业

    房地          近期房地产股表现一直不错,在周二上涨基础上昨日再度居于涨幅前列。     地产业景气度下滑已经确定,但2008年受财务运作和销售滞后影响,业绩仍有望高速增长。目前房价虽然出现明显下跌,但房地产投资增速同样放缓,供给有可能在今后几年内重新达成平衡。因此,房地产价格陷入欧美式恐慌性下跌的可能性不大。东方             中粮地产

    产业